The global CROs Services market size was valued at USD 78200 million in 2023 and is forecast to a readjusted size of USD 145040 million by 2030 with a CAGR of 9.2% during review period.
Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities.
The contract research organizations (CRO) services market is experiencing significant growth due to various factors. Factors such as increasing outsourcing of clinical trials by pharmaceutical and biotechnology companies, rising demand for specialized services, and the need for cost-effective drug development are driving market expansion. CROs offer a wide range of services, including clinical trial management, data management, regulatory affairs, and pharmacovigilance, providing expertise and operational support to clients. Additionally, advancements in technology and the growing complexity of clinical research further contribute to market growth. Moreover, the global expansion of clinical trials and the rising focus on personalized medicine fuel the demand for CRO services. However, factors such as stringent regulatory requirements and challenges in data quality management may pose hurdles to market growth.
This report includes an overview of the development of the CROs Services industry chain, the market status of Pre-clinical (Full-Service CRO, Functional Service Provision CRO), Clinical I-â…¢ (Full-Service CRO, Functional Service Provision CRO), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of CROs Services.
Regionally, the report analyzes the CROs Services markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global CROs Services market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the CROs Services market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the CROs Services industry.
The report involves analyzing the market at a macro level:
Âé¶¹Ô´´ Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Full-Service CRO, Functional Service Provision CRO).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the CROs Services market.
Regional Analysis: The report involves examining the CROs Services market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Âé¶¹Ô´´ Projections: Report covers the gathered data and analysis to make future projections and forecasts for the CROs Services market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to CROs Services:
Company Analysis: Report covers individual CROs Services players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards CROs Services This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pre-clinical, Clinical I-â…¢).
Technology Analysis: Report covers specific technologies relevant to CROs Services. It assesses the current state, advancements, and potential future developments in CROs Services areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the CROs Services market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Âé¶¹Ô´´ Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Âé¶¹Ô´´ Segmentation
CROs Services market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Âé¶¹Ô´´ segment by Type
Full-Service CRO
Functional Service Provision CRO
Âé¶¹Ô´´ segment by Application
Pre-clinical
Clinical I-â…¢
Other
Âé¶¹Ô´´ segment by players, this report covers
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Charles River Laboratories International Inc (CRL)
Hangzhou Tigermed
Clinipace
PSI CRO
Pierrel Research
Âé¶¹Ô´´ segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe CROs Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of CROs Services, with revenue, gross margin and global market share of CROs Services from 2019 to 2024.
Chapter 3, the CROs Services competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and CROs Services market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of CROs Services.
Chapter 13, to describe CROs Services research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Âé¶¹Ô´´ Overview
1.1 Product Overview and Scope of CROs Services
1.2 Âé¶¹Ô´´ Estimation Caveats and Base Year
1.3 Classification of CROs Services by Type
1.3.1 Overview: Global CROs Services Âé¶¹Ô´´ Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global CROs Services Consumption Value Âé¶¹Ô´´ Share by Type in 2023
1.3.3 Full-Service CRO
1.3.4 Functional Service Provision CRO
1.4 Global CROs Services Âé¶¹Ô´´ by Application
1.4.1 Overview: Global CROs Services Âé¶¹Ô´´ Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pre-clinical
1.4.3 Clinical I-â…¢
1.4.4 Other
1.5 Global CROs Services Âé¶¹Ô´´ Size & Forecast
1.6 Global CROs Services Âé¶¹Ô´´ Size and Forecast by Region
1.6.1 Global CROs Services Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global CROs Services Âé¶¹Ô´´ Size by Region, (2019-2030)
1.6.3 North America CROs Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.4 Europe CROs Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.5 Asia-Pacific CROs Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.6 South America CROs Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
1.6.7 Middle East and Africa CROs Services Âé¶¹Ô´´ Size and Prospect (2019-2030)
2 Company Profiles
2.1 IQVIA
2.1.1 IQVIA Details
2.1.2 IQVIA Major Business
2.1.3 IQVIA CROs Services Product and Solutions
2.1.4 IQVIA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.1.5 IQVIA Recent Developments and Future Plans
2.2 Labcorp
2.2.1 Labcorp Details
2.2.2 Labcorp Major Business
2.2.3 Labcorp CROs Services Product and Solutions
2.2.4 Labcorp CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.2.5 Labcorp Recent Developments and Future Plans
2.3 Syneos Health
2.3.1 Syneos Health Details
2.3.2 Syneos Health Major Business
2.3.3 Syneos Health CROs Services Product and Solutions
2.3.4 Syneos Health CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.3.5 Syneos Health Recent Developments and Future Plans
2.4 PPD
2.4.1 PPD Details
2.4.2 PPD Major Business
2.4.3 PPD CROs Services Product and Solutions
2.4.4 PPD CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.4.5 PPD Recent Developments and Future Plans
2.5 ICON
2.5.1 ICON Details
2.5.2 ICON Major Business
2.5.3 ICON CROs Services Product and Solutions
2.5.4 ICON CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.5.5 ICON Recent Developments and Future Plans
2.6 PRA
2.6.1 PRA Details
2.6.2 PRA Major Business
2.6.3 PRA CROs Services Product and Solutions
2.6.4 PRA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.6.5 PRA Recent Developments and Future Plans
2.7 Parexel
2.7.1 Parexel Details
2.7.2 Parexel Major Business
2.7.3 Parexel CROs Services Product and Solutions
2.7.4 Parexel CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.7.5 Parexel Recent Developments and Future Plans
2.8 Medpace
2.8.1 Medpace Details
2.8.2 Medpace Major Business
2.8.3 Medpace CROs Services Product and Solutions
2.8.4 Medpace CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.8.5 Medpace Recent Developments and Future Plans
2.9 Wuxi Apptec
2.9.1 Wuxi Apptec Details
2.9.2 Wuxi Apptec Major Business
2.9.3 Wuxi Apptec CROs Services Product and Solutions
2.9.4 Wuxi Apptec CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.9.5 Wuxi Apptec Recent Developments and Future Plans
2.10 EPS International
2.10.1 EPS International Details
2.10.2 EPS International Major Business
2.10.3 EPS International CROs Services Product and Solutions
2.10.4 EPS International CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.10.5 EPS International Recent Developments and Future Plans
2.11 Worldwide Clinical Trials
2.11.1 Worldwide Clinical Trials Details
2.11.2 Worldwide Clinical Trials Major Business
2.11.3 Worldwide Clinical Trials CROs Services Product and Solutions
2.11.4 Worldwide Clinical Trials CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.11.5 Worldwide Clinical Trials Recent Developments and Future Plans
2.12 CMIC
2.12.1 CMIC Details
2.12.2 CMIC Major Business
2.12.3 CMIC CROs Services Product and Solutions
2.12.4 CMIC CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.12.5 CMIC Recent Developments and Future Plans
2.13 Premier Research
2.13.1 Premier Research Details
2.13.2 Premier Research Major Business
2.13.3 Premier Research CROs Services Product and Solutions
2.13.4 Premier Research CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.13.5 Premier Research Recent Developments and Future Plans
2.14 Courante Oncology
2.14.1 Courante Oncology Details
2.14.2 Courante Oncology Major Business
2.14.3 Courante Oncology CROs Services Product and Solutions
2.14.4 Courante Oncology CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.14.5 Courante Oncology Recent Developments and Future Plans
2.15 PROMETRIKA
2.15.1 PROMETRIKA Details
2.15.2 PROMETRIKA Major Business
2.15.3 PROMETRIKA CROs Services Product and Solutions
2.15.4 PROMETRIKA CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.15.5 PROMETRIKA Recent Developments and Future Plans
2.16 Charles River Laboratories International Inc (CRL)
2.16.1 Charles River Laboratories International Inc (CRL) Details
2.16.2 Charles River Laboratories International Inc (CRL) Major Business
2.16.3 Charles River Laboratories International Inc (CRL) CROs Services Product and Solutions
2.16.4 Charles River Laboratories International Inc (CRL) CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.16.5 Charles River Laboratories International Inc (CRL) Recent Developments and Future Plans
2.17 Hangzhou Tigermed
2.17.1 Hangzhou Tigermed Details
2.17.2 Hangzhou Tigermed Major Business
2.17.3 Hangzhou Tigermed CROs Services Product and Solutions
2.17.4 Hangzhou Tigermed CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.17.5 Hangzhou Tigermed Recent Developments and Future Plans
2.18 Clinipace
2.18.1 Clinipace Details
2.18.2 Clinipace Major Business
2.18.3 Clinipace CROs Services Product and Solutions
2.18.4 Clinipace CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.18.5 Clinipace Recent Developments and Future Plans
2.19 PSI CRO
2.19.1 PSI CRO Details
2.19.2 PSI CRO Major Business
2.19.3 PSI CRO CROs Services Product and Solutions
2.19.4 PSI CRO CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.19.5 PSI CRO Recent Developments and Future Plans
2.20 Pierrel Research
2.20.1 Pierrel Research Details
2.20.2 Pierrel Research Major Business
2.20.3 Pierrel Research CROs Services Product and Solutions
2.20.4 Pierrel Research CROs Services Revenue, Gross Margin and Âé¶¹Ô´´ Share (2019-2024)
2.20.5 Pierrel Research Recent Developments and Future Plans
3 Âé¶¹Ô´´ Competition, by Players
3.1 Global CROs Services Revenue and Share by Players (2019-2024)
3.2 Âé¶¹Ô´´ Share Analysis (2023)
3.2.1 Âé¶¹Ô´´ Share of CROs Services by Company Revenue
3.2.2 Top 3 CROs Services Players Âé¶¹Ô´´ Share in 2023
3.2.3 Top 6 CROs Services Players Âé¶¹Ô´´ Share in 2023
3.3 CROs Services Âé¶¹Ô´´: Overall Company Footprint Analysis
3.3.1 CROs Services Âé¶¹Ô´´: Region Footprint
3.3.2 CROs Services Âé¶¹Ô´´: Company Product Type Footprint
3.3.3 CROs Services Âé¶¹Ô´´: Company Product Application Footprint
3.4 New Âé¶¹Ô´´ Entrants and Barriers to Âé¶¹Ô´´ Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Âé¶¹Ô´´ Size Segment by Type
4.1 Global CROs Services Consumption Value and Âé¶¹Ô´´ Share by Type (2019-2024)
4.2 Global CROs Services Âé¶¹Ô´´ Forecast by Type (2025-2030)
5 Âé¶¹Ô´´ Size Segment by Application
5.1 Global CROs Services Consumption Value Âé¶¹Ô´´ Share by Application (2019-2024)
5.2 Global CROs Services Âé¶¹Ô´´ Forecast by Application (2025-2030)
6 North America
6.1 North America CROs Services Consumption Value by Type (2019-2030)
6.2 North America CROs Services Consumption Value by Application (2019-2030)
6.3 North America CROs Services Âé¶¹Ô´´ Size by Country
6.3.1 North America CROs Services Consumption Value by Country (2019-2030)
6.3.2 United States CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.3 Canada CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
6.3.4 Mexico CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7 Europe
7.1 Europe CROs Services Consumption Value by Type (2019-2030)
7.2 Europe CROs Services Consumption Value by Application (2019-2030)
7.3 Europe CROs Services Âé¶¹Ô´´ Size by Country
7.3.1 Europe CROs Services Consumption Value by Country (2019-2030)
7.3.2 Germany CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.3 France CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.4 United Kingdom CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.5 Russia CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
7.3.6 Italy CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific CROs Services Consumption Value by Type (2019-2030)
8.2 Asia-Pacific CROs Services Consumption Value by Application (2019-2030)
8.3 Asia-Pacific CROs Services Âé¶¹Ô´´ Size by Region
8.3.1 Asia-Pacific CROs Services Consumption Value by Region (2019-2030)
8.3.2 China CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.3 Japan CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.4 South Korea CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.5 India CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.6 Southeast Asia CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
8.3.7 Australia CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9 South America
9.1 South America CROs Services Consumption Value by Type (2019-2030)
9.2 South America CROs Services Consumption Value by Application (2019-2030)
9.3 South America CROs Services Âé¶¹Ô´´ Size by Country
9.3.1 South America CROs Services Consumption Value by Country (2019-2030)
9.3.2 Brazil CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
9.3.3 Argentina CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa CROs Services Consumption Value by Type (2019-2030)
10.2 Middle East & Africa CROs Services Consumption Value by Application (2019-2030)
10.3 Middle East & Africa CROs Services Âé¶¹Ô´´ Size by Country
10.3.1 Middle East & Africa CROs Services Consumption Value by Country (2019-2030)
10.3.2 Turkey CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.3 Saudi Arabia CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
10.3.4 UAE CROs Services Âé¶¹Ô´´ Size and Forecast (2019-2030)
11 Âé¶¹Ô´´ Dynamics
11.1 CROs Services Âé¶¹Ô´´ Drivers
11.2 CROs Services Âé¶¹Ô´´ Restraints
11.3 CROs Services Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 CROs Services Industry Chain
12.2 CROs Services Upstream Analysis
12.3 CROs Services Midstream Analysis
12.4 CROs Services Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Charles River Laboratories International Inc (CRL)
Hangzhou Tigermed
Clinipace
PSI CRO
Pierrel Research
Ìý
Ìý
*If Applicable.